A CCRK-EZH2 epigenetic circuitry drives hepatocarcinogenesis and associates with tumor recurrence and poor survival of patientsHai Feng, Alfred S.L. Cheng, Andrew M. Chan et al.|Journal of Hepatology|2014Cited by 76
Loss of tumor suppressor IGFBP4 drives epigenetic reprogramming in hepatic carcinogenesisYing‐Ying Lee, Alfred S.L. Cheng, Myth T.S. Mok et al.|Nucleic Acids Research|2018Cited by 67
Cell cycle-related kinase mediates viral-host signalling to promote hepatitis B virus-associated hepatocarcinogenesisZhuo Yu, Alfred S.L. Cheng, Yueqiu Gao et al.|Gut|2014Cited by 63
Yin Yang 1‐mediated epigenetic silencing of tumour‐suppressive microRNAs activates nuclear factor‐κB in hepatocellular carcinomaDaisy PF Tsang, Alfred S.L. Cheng, William Ka Kei Wu et al.|The Journal of Pathology|2016Cited by 60